Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

about

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer.

P2860

Q55392681-890F1643-D2E4-42A9-918E-3EC656CCB4E4

P2860

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

Item

http://www.wikidata.org/entity/Q45049735

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

@en

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

@nl

type

Item

label

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

@en

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

@nl

prefLabel

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

@en

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

@nl

P1476

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

@en

P2093

Jeffrey Vacirca

http://www.w3.org/2001/XMLSchema#string

Siva Narayanan

http://www.w3.org/2001/XMLSchema#string

Vincent Picozzi

http://www.w3.org/2001/XMLSchema#string

X Henry Hu

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.

Progress in the knowledge and treatment of advanced pancreatic cancer: from benchside to bedside.

Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review.

P2888

s12029-016-9902-9

P304

103-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12029-016-9902-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036220553

http://www.w3.org/2001/XMLSchema#string

P698

28028766

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

about

P2860

P2860

Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921